From: Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
Variable | Subgroups | OR | 95% CI | p value |
---|---|---|---|---|
Sex | Female (Ref) | |||
Male | 0.9 | 0.7–1.12 | 0.6 | |
Age (Years) | 1.02 | 1.01–1.03 | 0.02* | |
Duration of DM (Years) | 1.1 | 0.99–1.03 | 0.42 | |
Medical history | ||||
Smoking | 1.12 | 0.95–1.3 | 0.17 | |
Hypertension | 1.4 | 1.1–1.8 | 0.03* | |
CAD | 0.9 | 0.6–1.3 | 0.44 | |
Stroke | 1.4 | 0.9–2.2 | 0.16 | |
Neuropathy | 1.24 | 1.01–1.6 | <0.05* | |
Retinopathy | 1.3 | 1.01–1.7 | <0.05* | |
Medications | Insulin | 1.38 | 1.1–1.7 | 0.01* |
Metformin | 0.42 | 0.33–0.55 | <0.01* | |
ACEIs/ARBs | 0.8 | 0.6–1.1 | 0.1 | |
Beta blockers | 1.3 | 1.01–1.7 | 0.02* | |
Diuretics | 1.4 | 1.1–1.8 | 0.01* | |
CCB | 1.4 | 1.1–1.9 | <0.01* | |
Triglyceride’s level (mg/dl) | 1.1 | 1.01–1.2 | <0.01* | |
HDL (mg/dl) | 0.98 | 0.97–0.99 | <0.01* |